Suppr超能文献

包裹于聚合物胶束中的酮咯酸:制备、表征及眼部抗炎研究

Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies.

作者信息

Gupta A K, Madan S, Majumdar D K, Maitra A

机构信息

Department of Chemistry, University of Delhi, 110 007, Delhi, India.

出版信息

Int J Pharm. 2000 Nov 19;209(1-2):1-14. doi: 10.1016/s0378-5173(00)00508-1.

Abstract

Polymeric micelles made of copolymer of N-isopropylacrylamide (NIPAAM), vinyl pyrrolidone (VP) and acrylic acid (AA) having cross-linkage with N,N'-methylene bis-acrylamide (MBA) were used as host carrier in which up to 30%w/w ketorolac (free acid) was entrapped to make the formulation. The lyophilised powder was used for physical characterisation. The drug entrapment was found to be about 80% and the formulation was stable for 8-10 days at room temperature. The smaller the amount of ketorolac dissolved into the micelles, the longer was the formulation shelf life. The size of the particles as measured by dynamic light scattering was found to be around 35 nm diameter at 25 degrees C. TEM picture showed spherical particles. The structure of the polymer and its morphology were characterised by FTIR, NMR and XRD measurements. IR data indicated weak interaction between polymer and ketorolac in the encapsulated system. NMR spectra indicated rigid polymer backbone with intermittent iso-propyl group in the chain. XRD spectra showed significant loss of crystallinity of the drug while being entrapped in the polymeric micelles. The release of drug in aqueous buffer (pH 7.2) from the polymeric micelles at 25 degrees C were 20 and 60% after 2 and 8 h respectively and is temperature and pH dependent. In vitro corneal permeation studies through excised rabbit cornea indicated two fold increase in ocular availability with no corneal damage compared to an aqueous suspension containing same amount of drug as in nanoparticles. The formulation showed significant inhibition of lid closure up to 3 h and PMN migration up to 5 h compared to the suspension containing non-entrapped drug, which did not show any significant effect.

摘要

由N-异丙基丙烯酰胺(NIPAAM)、乙烯基吡咯烷酮(VP)和丙烯酸(AA)的共聚物制成并与N,N'-亚甲基双丙烯酰胺(MBA)交联的聚合物胶束用作主体载体,其中包裹了高达30%w/w的酮咯酸(游离酸)以制成该制剂。冻干粉末用于物理表征。发现药物包封率约为80%,该制剂在室温下可稳定保存8 - 10天。溶解在胶束中的酮咯酸量越少,制剂的保质期越长。通过动态光散射测量,在25℃下颗粒大小约为直径35nm。透射电镜照片显示为球形颗粒。通过傅里叶变换红外光谱(FTIR)、核磁共振(NMR)和X射线衍射(XRD)测量对聚合物的结构及其形态进行了表征。红外数据表明在包封体系中聚合物与酮咯酸之间存在弱相互作用。核磁共振光谱表明聚合物主链刚性,链中存在间歇性异丙基。X射线衍射光谱显示药物在被包裹在聚合物胶束中时结晶度显著降低。在25℃下,聚合物胶束在水性缓冲液(pH 7.2)中药物的释放率在2小时和8小时后分别为20%和60%,且与温度和pH有关。通过切除的兔角膜进行的体外角膜渗透研究表明,与含有相同量药物的水性悬浮液相比,纳米颗粒制剂的眼部可用性提高了两倍,且无角膜损伤。与含有未包裹药物的悬浮液相比,该制剂在长达3小时内对眼睑闭合有显著抑制作用,在长达5小时内对中性粒细胞迁移有显著抑制作用,而后者未显示任何显著效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验